9 results on '"Hua Zheng"'
Search Results
2. Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
- Author
-
Min Liu, Bo Peng, Wei Sun, Yuan Feng, Jun-Hua Zheng, Xudong Yao, and Yunfei Xu
- Subjects
Adult ,Male ,medicine.medical_specialty ,Article Subject ,Urinary system ,Angiotensinogen ,Urology ,lcsh:Medicine ,Renal function ,Urine ,Nephrolithiasis ,General Biochemistry, Genetics and Molecular Biology ,chemistry.chemical_compound ,Internal medicine ,Alpha-Globulins ,Humans ,Medicine ,In patient ,Normal control ,Creatinine ,General Immunology and Microbiology ,business.industry ,lcsh:R ,General Medicine ,Middle Aged ,medicine.disease ,Endocrinology ,chemistry ,Case-Control Studies ,Biomarker (medicine) ,Female ,business ,Research Article ,Glomerular Filtration Rate ,Kidney disease - Abstract
Background.Elevated urinary angiotensinogen (UA) was identified as novel prognostic biomarker capable of predicting chronic kidney disease, and in the present study, we will investigate the diagnostic value of UA in the patients of nephrolithiasis.Methods.Urine angiotensinogen levels andα1-microglobulin were measured by enzyme-linked immunosorbent assay (ELISA) in 60 patients presenting with nephrolithiasis and 50 sex- and age-matched healthy volunteers. Estimated glomerular filtration (eGFR) was calculated and, by simple regression analysis, the correlation of UA/α1-microglobulin levels and the decline of eGFR were analyzed as well.Results.Median UA levels was significantly increased in the nephrolithiasis patients compared with normal control (1250.78±439.27 versus 219.34±45.27 pg/mL;P<0.01). The mean serum creatinine levels in patients with higher UA levels (>1250 pg/mL) was significantly higher than those with lower UA levels (<1250 pg/mL) [92.23±18.13 μmol/L versus 70.07±11.17 μmol/L;P<0.05]. According to the single variate analysis, UA levels were significantly and positively correlated with urinaryα1-microglobulin (r=0.733;P=1.33×10-15), while they were significantly and negatively correlated with eGFR (r=-0.343;P=1.03×10-4).Conclusion.Urinary UA is a novel biomarker for patients with nephrolithiasis, which indicates renal tubular injury. Further study on the molecular pathogenic mechanism of UA and larger scale of clinical trial is required.
- Published
- 2014
3. Elevated Levels of miR-155 in Blood and Urine from Patients with Nephrolithiasis
- Author
-
Min Liu, Jun-Hua Zheng, Xudong Yao, Yunfei Xu, Yangyang Hu, Bo Peng, and Weida Dong
- Subjects
Male ,medicine.medical_specialty ,Article Subject ,Urinary system ,lcsh:Medicine ,Renal function ,Urine ,Nephrolithiasis ,General Biochemistry, Genetics and Molecular Biology ,Proinflammatory cytokine ,Internal medicine ,medicine ,Humans ,General Immunology and Microbiology ,biology ,lcsh:R ,C-reactive protein ,Case-control study ,Interleukin ,General Medicine ,Middle Aged ,medicine.disease ,MicroRNAs ,C-Reactive Protein ,Endocrinology ,Gene Expression Regulation ,Case-Control Studies ,biology.protein ,Cytokines ,Female ,Glomerular Filtration Rate ,Research Article ,Kidney disease - Abstract
Background.Both circulating and urinary miRNAs may represent a potential noninvasive molecular biomarker capable of predicting chronic kidney disease, and, in the present study, we will investigate the serum and urinary levels of miR-155 in patients with nephrolithiasis.Methods.Serum and urinary levels of miR-155 are quantified in 60 patients with nephrolithiasis; the result was compared to 50 healthy volunteers. Estimated glomerular filtration (eGFR) was calculated and, by simple regression analysis, the correlations of miR-155/eGFR and miR-155/CRP (C-reactive protein) levels were analyzed as well.Results.The median levels of serum and urinary levels of miR-155 are significantly higher in nephrolithiasis patients than in controls. eGFR inversely correlates with urinary level of miR-155; CRP positively correlates with urinary miR-155. Urinary level of miR-155 inversely correlates with urinary expression of interleukin- (IL-) 1β, IL-6, and tumor necrosis factor- (TNF-)αand positively correlates with urinary expression of regulated upon activation, normal T-cell expressed, and secreted (RANTES).Conclusion.Serum and urinary levels of miR-155 were significantly elevated in patients with nephrolithiasis, and the upregulation of miR-155 was correlated with decline of eGFR and elevation of CRP. Our results suggested that miR-155 might play important roles in the pathophysiology of nephrolithiasis via regulating inflammatory cytokines expression. Further study on the molecular pathogenic mechanism and larger scale of clinical trial are required.
- Published
- 2014
4. Role of Long Noncoding RNA HOTAIR in the Growth and Apoptosis of Osteosarcoma Cell MG-63
- Author
-
Hua Zheng and Jing Min
- Subjects
0301 basic medicine ,Article Subject ,General Immunology and Microbiology ,medicine.diagnostic_test ,Cell growth ,lcsh:R ,Cell ,lcsh:Medicine ,Osteoblast ,HOTAIR ,General Medicine ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Flow cytometry ,03 medical and health sciences ,030104 developmental biology ,medicine.anatomical_structure ,Cell culture ,Apoptosis ,medicine ,Cancer research ,MTT assay ,Research Article - Abstract
This study investigated the function of HOTAIR in the growth and apoptosis of OS MG-63 cell linein vitroand further clarified its mechanism. The expression levels of HOTAIR in OS MG-63 cell line and normal osteoblast hFOB1.19 cell line were determined by RT-PCR, respectively. The growth and apoptosis of MG-63 cellsin vitrowere investigated by MTT assay and flow cytometry assay after HOTAIR was knocked down with retroviral vector construction. And the expression levels of cell growth and apoptosis related factors TGF-β, p53, Bcl-2, and TNF-αwere determined to clarify the mechanism. We found that HOTAIR was highly expressed in osteosarcoma MG-63 cell line compared with normal osteoblast hFOB1.19 cell line. The proliferation rate was lower and the apoptosis rate was higher significantly in shHOTAIR MG-63 cells than those in EV MG-63 cells. TGF-βand Bcl-2 were downregulated significantly when HOTAIR was knocked down. p53 and TNF-αwere upregulated significantly when HOTAIR was knocked down. These results indicated that HOTAIR functioned as a carcinogenic lncRNA, which could promote the proliferation and inhibit the apoptosis of MG-63 cellsin vitro. HOTAIR could be a potential target for the treatment of osteosarcoma.
- Published
- 2016
5. Bioguided Fraction and Isolation of the Antitumor Components from
- Author
-
Zhi-Zhong, Zheng, Liang-Hua, Chen, Shao-Song, Liu, Yuan, Deng, Guo-Hua, Zheng, Yue, Gu, and Yan-Lin, Ming
- Subjects
Phyllanthus ,Magnetic Resonance Spectroscopy ,Glucosides ,Cell Line, Tumor ,Neoplasms ,Humans ,Antineoplastic Agents ,Hydrolyzable Tannins ,Cell Proliferation ,Research Article - Abstract
Phyllanthus niruri L., a well-known medicinal plant, has been used as a folk antitumor remedy in the worldwide scale. However, the antitumor components in P. niruri have not been reported. In order to verify the antitumor components of P. niruri and the plants which have the high content of these components, we isolated the antitumor components with bioguided fraction and isolation, by different chromatographic methods from the ethyl acetate fraction of P. niruri., and identified them as ethyl brevifolincarboxylate and corilagin by 1H-NMR, 13C-NMR, 2D-NMR, and mass spectrometric analyses. Cell cytotoxicity assays showed that corilagin has broad-spectrum antitumor activity, a better antitumor potential, and lower toxicity in normal cells. Besides, the coefficient of drug interaction (CDI) of 10 μM corilagin and 20 μM cDDP reached up to 0.77, which means corilagin can promote the antitumor activity of cDDP. Furthermore, by the extensive screening among 10 species of plants reported to contain corilagin, we found that Dimocarpus longan Lour. has the maximum content of corilagin. In conclusion, corilagin is the major active antitumor composition in P. niruri. L. on HCC cells and has high content in D. longan.
- Published
- 2016
6. Fibrinogen Alpha Chain Precursor and Apolipoprotein A-I in Urine as Biomarkers for Noninvasive Diagnosis of Calcium Oxalate Nephrolithiasis: A Proteomics Study
- Author
-
Min Liu, Guang-Chun Wang, Wei Zhu, Jun-Hua Zheng, Bo Peng, Jian-Ping Che, Yang Yan, Xudong Yao, and Qing-Wei Ma
- Subjects
Adult ,Male ,Proteomics ,medicine.medical_specialty ,Article Subject ,Apolipoprotein B ,Urinary system ,lcsh:Medicine ,Urine ,Fibrinogen ,Nephrolithiasis ,Gastroenterology ,Sensitivity and Specificity ,General Biochemistry, Genetics and Molecular Biology ,Internal medicine ,medicine ,Humans ,Fibrinogen alpha chain ,General Immunology and Microbiology ,biology ,Apolipoprotein A-I ,lcsh:R ,Case-control study ,Area under the curve ,General Medicine ,Endocrinology ,Case-Control Studies ,biology.protein ,Female ,Biomarkers ,medicine.drug ,Research Article - Abstract
Calcium oxalate nephrolithiasis is the most common urological disease, but noninvasive and convenient methods of diagnosis are rarely available.Objective.The present study aimed to identify potential urine biomarkers for noninvasive diagnosis of CaOx nephrolithiasis.Methodology.Urine samples from 72 patients with CaOx nephrolithiasis and 30 healthy controls were collected and proteomics analysis was performed using matrix-assisted laser desorption/ionization-time of flight-mass spectrometer (MALDI-TOF-MS).Results.Thirteen proteins/peptides displayed statistically significant differences. The peptides of m/z 1207.23 and 2773.86 were selected by the genetic algorithm (GA) to build a possible diagnostic model. The area under the curve of m/z 1207.23 and 2773.86 was 0.936 and 0.987, respectively. The diagnostic model in distinguishing patients and healthy subjects showed 100% sensitivity and specificity. The peak at m/z 2773.86 was identified as fibrinogen alpha chain (FGA) with the sequence G.EGDFLAEGGGVR.G, and the peak at m/z 2773.86 was identified as apolipoprotein A-I (apoA-I) with the sequence L.PVLESFKVSFLSALEEYTKKLNTQ.Conclusion.The study results strongly suggested that urinary FGA and apoA-I are highly sensitive and specific biomarkers for noninvasive diagnosis of CaOx nephrolithiasis.
- Published
- 2014
7. Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.
- Author
-
Mao-hua Zheng, Hong-tao Sun, Ji-guang Xu, Gang Yang, Lei-ming Huo, Pan Zhang, Jin-hui Tian, and Ke-hu Yang
- Subjects
- *
BRAIN tumor treatment , *LUNG cancer complications , *CANCER treatment , *METASTASIS , *GEFITINIB , *ERLOTINIB , *ANTINEOPLASTIC agents , *BRAIN tumors , *CENTRAL nervous system , *CONFIDENCE intervals , *INFORMATION storage & retrieval systems , *MEDICAL databases , *MEDICAL information storage & retrieval systems , *MEDLINE , *META-analysis , *ONLINE information services , *QUALITY assurance , *RANDOMIZED controlled trials , *TREATMENT effectiveness , *DISEASE remission , *DATA analysis software , *ADVERSE health care events , *ODDS ratio , *CHEMORADIOTHERAPY , *PROGNOSIS , *THERAPEUTICS - Abstract
Background. To comprehensively assess the efficacy and safety of whole-brain radiotherapy (WBRT) combined with gefitinib/erlotinib for treatment of brain metastases (BM) from non-small-cell lung cancer (NSCLC). Methods. Databases including PubMed, EMBASE.com, Web of Science, and Cochrane Library were searched from inception to April 12, 2015. Studies on randomized controlled trials (RCTs) and case-control trials comparing WBRT combined with gefitinib/erlotinib versus WBRT alone for BM from NSCLC were included. Literature selection, data extraction, and quality assessment were performed independently by two trained reviewers. RevMan 5.3 software was used to analyze data. Results. A total of 7 trials involving 622 patients were included. Compared with WBRT alone or WBRT plus chemotherapy, WBRT plus gefitinib/erlotinib could significantly improve response rate (OR = 2.16, 95% CI: 1.35-3.47; P = 0.001), remission rate of central nervous system (OR = 6.06, 95% CI: 2.57-14.29; P < 0.0001), disease control rate (OR = 3.34, 95% CI: 1.84-6.07; P < 0.0001), overall survival (HR = 0.72, 95% CI: 0.58-0.89; P = 0.002), and 1-year survival rate (OR = 2.43, 95% CI: 1.51-3.91; P = 0.0002). In adverse events (III-IV), statistically significant differences were not found, except for rash (OR = 7.96, 95% CI: 2.02-31.34; P = 0.003) and myelosuppression (OR = 0.19, 95% CI: 0.07-0.51; P = 0.0010). Conclusions.WBRT plus gefitinib/erlotinib was superior to WBRT alone and well tolerated in patients with BM from NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis.
- Author
-
Wei Sun, Yuan Feng, Xu-Dong Yao, Yun-Fei Xu, Bo Peng, Min Liu, and Jun-Hua Zheng
- Abstract
Background. Elevated urinary angiotensinogen (UA) was identified as novel prognostic biomarker capable of predicting chronic kidney disease, and in the present study, we will investigate the diagnostic value of UA in the patients of nephrolithiasis. Methods. Urine angiotensinogen levels and α1-microglobulin were measured by enzyme-linked immunosorbent assay (ELISA) in 60 patients presenting with nephrolithiasis and 50 sex- and age-matched healthy volunteers. Estimated glomerular filtration (eGFR) was calculated and, by simple regression analysis, the correlation of UA/α1-microglobulin levels and the decline of eGFR were analyzed as well. Results. Median UA levels was significantly increased in the nephrolithiasis patients compared with normal control (1250.78 ± 439.27 versus 219.34 ± 45.27 pg/mL; P < 0.01). The mean serumcreatinine levels in patients with higher UA levels (>1250 pg/mL) was significantly higher than those with lower UA levels (<1250 pg/mL) [92.23 ± 18.13 μmol/L versus 70.07 ± 11.17 μmol/L; P < 0.05]. According to the single variate analysis, UA levels were significantly and positively correlated with urinary α1-microglobulin (r = 0.733; P = 1.33 × 10
-15 ), while they were significantly and negatively correlated with eGFR (r = -0.343; P = 1.03 × 10-4 ). Conclusion. Urinary UA is a novel biomarker for patients with nephrolithiasis, which indicates renal tubular injury. Further study on the molecular pathogenic mechanism of UA and larger scale of clinical trial is required. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
9. Elevated Levels of miR-155 in Blood and Urine from Patients with Nephrolithiasis.
- Author
-
Yang-Yang Hu, Wei-Da Dong, Yun-Fei Xu, Xu-Dong Yao, Bo Peng, Min Liu, and Jun-Hua Zheng
- Abstract
Background. Both circulating and urinary miRNAs may represent a potential noninvasive molecular biomarker capable of predicting chronic kidney disease, and, in the present study, we will investigate the serum and urinary levels of miR-155 in patients with nephrolithiasis. Methods. Serum and urinary levels of miR-155 are quantified in 60 patients with nephrolithiasis; the result was compared to 50 healthy volunteers. Estimated glomerular filtration (eGFR) was calculated and, by simple regression analysis, the correlations of miR-155/eGFR and miR-155/CRP (C-reactive protein) levels were analyzed as well. Results. The median levels of serum and urinary levels of miR-155 are significantly higher in nephrolithiasis patients than in controls. eGFR inversely correlates with urinary level of miR-155; CRP positively correlates with urinary miR-155. Urinary level of miR-155 inversely correlates with urinary expression of interleukin- (IL-) 1β, IL-6, and tumor necrosis factor- (TNF-) α and positively correlates with urinary expression of regulated upon activation, normal T-cell expressed, and secreted (RANTES). Conclusion. Serumand urinary levels of miR-155 were significantly elevated in patients with nephrolithiasis, and the upregulation of miR-155 was correlated with decline of eGFR and elevation of CRP. Our results suggested that miR-155 might play important roles in the pathophysiology of nephrolithiasis via regulating inflammatory cytokines expression. Further study on themolecular pathogenic mechanism and larger scale of clinical trial are required. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.